Business Description
Paion AG
SIC : 2834
ISIN : DE000A3E5EG5
Compare
Compare
Traded in other countries / regions
PA8.GermanyPAIOF.USA0NF3.UK IPO Date
2005-02-11Description
Paion AG is a German specialty pharmaceutical company focused on developing and commercializing drugs for procedural sedation, anesthesia, and critical care. Its lead product is remimazolam, an ultra-short-acting intravenous benzodiazepine sedative that is rapidly metabolized by tissue esterases rather than cytochrome-dependent hepatic pathways, making it suitable for procedures such as bronchoscopy, colonoscopy, and general anesthesia. Paion develops and out-licenses remimazolam to partners in various territories, including the United States, China, Japan, and other markets, generating revenue through licensing fees, milestones, and royalties, as well as through direct sales in selected European countries. The company is headquartered in Aachen, Germany, and its shares are listed on the Frankfurt Stock Exchange.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 43.93 | |||||
9-Day RSI | 46.36 | |||||
14-Day RSI | 46.96 | |||||
3-1 Month Momentum % | -18.52 | |||||
6-1 Month Momentum % | -38.89 | |||||
12-1 Month Momentum % | 388.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 0.03 | |||||
EV-to-Forward-EBITDA | 65.95 | |||||
EV-to-Forward-Revenue | 22.77 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Paion AG Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 14.808 | ||
| EPS (TTM) (€) | -2.784 | ||
| Beta | 7.1171 | ||
| 3-Year Sharpe Ratio | 0.58 | ||
| 3-Year Sortino Ratio | 2.16 | ||
| Volatility % | 555.67 | ||
| 14-Day RSI | 46.96 | ||
| 14-Day ATR (€) | 0.002703 | ||
| 20-Day SMA (€) | 0.047225 | ||
| 12-1 Month Momentum % | 388.89 | ||
| 52-Week Range (€) | 0.009 - 0.23 | ||
| Shares Outstanding (Mil) | 7.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Paion AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Paion AG Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| 0.1:1 Stock Split | 2023-04-12 | 6.20 (-7.74%) |
Show
Entries
Paion AG Frequently Asked Questions
What is Paion AG(FRA:PA8)'s stock price today?
The current price of FRA:PA8 is €0.05. The 52 week high of FRA:PA8 is €0.23 and 52 week low is €0.01.
When is next earnings date of Paion AG(FRA:PA8)?
The next earnings date of Paion AG(FRA:PA8) is .
Does Paion AG(FRA:PA8) pay dividends? If so, how much?
Paion AG(FRA:PA8) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers